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Health care delivery systems across the globe
share a common goal: to provide efficient and
high-quality cancer care equitably to all patients.
As they strive to deliver such care, health care
systems struggle with increased detection capa-
bilities, diagnostic and treatment innovations,
substantial growth in the number of cancer
survivors, and shortages of some health care
personnel [1]. Inadequate cancer control poses
societal and economic harms, such as increased
public and private health care spending, de-
creased worker productivity, and increased job
loss [2]. Without an organizing framework to
prioritize goals for delivering cancer care that is
coupled with concrete action steps, nations will
face significant challenges to meet the needs of
people with cancer and their families.
In this issue of The Oncologist, a new policy
statement by the European Cancer Concord
(ECC) is a welcome first step to improve out-
comes for European patients with cancer and
their families [3].With apopulationofmore than
500million, the European Union (EU) has a large
and growing cancer burden [4]. Cancer is the
second leading cause of death in the EU, and EU
citizens are aging faster than other populations
[5].The ECC partnered with patients, caregivers,
clinicians, and advocates to construct three
articles that form a Patient’s Bill of Rights. These
include the rights to shared information and
decision making; timely access to appropriate
specialty care supported by research and in-
novation; and receipt of high-quality, affordable
care to achieve improved outcomes.These three
rights and their specific supporting tenets pro-
vide a foundation for pursuing legislative, regu-
latory, and programmatic changes that will be
needed in EU countries to decrease the societal
burden of cancer.
A major strength of the ECC initiative is its
broad engagement with patients, clinicians, and
other stakeholders across EU countries to articu-
late a patient-centered vision for improved
cancer care. As a key component, the ECC
developed its principles within the context of
widespread economic austerity measures and
rising costs of cancer care that require just and
cost-effective pricing of services to ensure
effective access. Importantly, the recommenda-
tions span the continuum of cancer care, from
cancer prevention through survivorship and
end-of-life care. These strengths can serve as
a catalyst for sustained improvements in cancer
care.
Amid these strengths, the Patient’s Bill of
Rights would be fortified by concrete action
steps to assure these rights are achieved. These
action steps should be considered within the
distinctive structural and cultural context in
which EU policy making occurs across national
boundaries. Moreover, transparent timelines
should be developed, and key stakeholders
should be identified to lead these action steps.
Inaddition,wepropose fourkeyactionstepsthat
will advance the agenda of the ECC. These
include (a) robust cancer registries, (b) monitor-
ing the quality of care, (c) broader stakeholder
engagement, and (d) dissemination of best
practices.
INVEST IN AND SUSTAIN ROBUST CANCER
REGISTRIES TO PRIORITIZE PROBLEMS AND
EVALUATE PROGRAMMATIC CHANGES
Substantial improvements in the cancer regis-
tries of EU nations will enable their health care
systems to monitor progress toward cancer
control priorities. Valid and reliable data are
necessary to understand the size and scope of
cancer burden within and across EU nations.
Population-based registries that capture inci-
dence, diagnosis, treatment, surveillance, and
survival data are instrumental to formulate
evidence-based cancer control plans [4, 6].With
reliable and valid data on cancer incidence,
treatment, and outcomes, these plans can miti-
gate the societal burden of cancer. Variations
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in care can be tracked to identify the presence or absence of
equitable treatment across important subgroups, including
immigrants who may be at risk for suboptimal care. Countries
across theEUvary in thequalityofcancer registry reporting [4].
Countries that have more experienced registries with higher-
quality data can share their expertise with countries that are
new to collecting these data. Over time these registries can be
linkedwith broader health systemdata on the use and costs of
healthcareservices forcancerpatients, ashasbeendone in the
U.S. through the SEER-Medicare database [7].
MONITOR THE QUALITY OF CANCER CARE
Efforts to monitor and improve the quality of cancer care are
a global priority [8]. Detailed recommendations to improve
cancer care in theU.S.were issued by the Institute ofMedicine
in 1999 [9]. More recently the Institute of Medicine has
highlighted the need to monitor and improve the care of
cancer survivors [10]. A core finding of these reports was the
need for evidence-based performance measures to monitor
the quality of cancer care. Quality of cancer care can be
assessed by measuring structure, process, and outcome
components. In addition to clinical outcome measures, data
sources for cancer care quality should incorporate the
perspectives of patients and providers. Although progress
has been made toward this goal over the past decade, many
challenges remain [11]. For the Patient’s Bill of Rights set forth
by the ECC, these mixed experiences with efforts to improve
cancercaresystems in theU.S.underscorethatachievingthese
rights will be a daunting task.
ENGAGE A BROADER GROUP OF STAKEHOLDERS THAT
INCLUDES OTHER HEALTH CARE PROFESSIONS,
LEGISLATORS, AND GOVERNMENT MINISTRIES
The ECC’s early work has established a working group of
stakeholder groups that span disciplines and countries. To
realize the goals of the efforts, deeper stakeholder engage-
ment is needed across three key areas. First, professional
societies in nursing, pharmacy, and general medical practice
should be engaged in implementing the Patient’s Bill of Rights.
These clinicians deliver substantial amounts of care to patients
with cancer. Their engagement will increase the likelihood
of programmatic success. For example, general practitioners
in Belgium, Italy, The Netherlands, and Spain have formed
collaborative networks to monitor end-of-life care, and
up to one-half of patients in these networks are dying of
cancer [12].
Second, increased connection to local, national, and EU
policy makers will assure policy development is harmonized
and congruent with the stated Bill of Rights. With well-
establishednational health systems inEuropean countries, the
policy makers who allocate resources to cancer care must be
fully engaged in efforts to achieve the best value in patient-
centered outcomes from these investments.
Third, participation by European countries with fewer
financial and clinical resources must be explicitly supported.
Depending on the basic elements of a cancer care plan, the
costs of full access to drugs, surgery, and irradiation (such as
proton therapy) may be prohibitive; it may be equally
important to emphasize early detection and prevention as
major initiatives insuchaplan,particularly for low-andmiddle-
incomecountries.Overall economichealthacross theEuropean
Union countries varies considerably, as does total health care
spending and government-funded health care spending [13].
These wide variations threaten equity in cancer treatment
across EU countries.The needs and challenges of countrieswith
fewer financial resources warrant increased attention and
support by EU and national policy makers.
DISSEMINATE BEST PRACTICES
Remarkable advances have been made in the prevention of
colorectal cancerandcervical cancerand in theearlydetection,
treatment, and supportive care for breast, colorectal, and
cervical cancer. Yet it is unclear whether these advances have
been disseminated broadly across care delivery systems.
Existing expertise is available to disseminate these efforts and
consult with less experienced delivery systems. Thus, the ECC
may wish to partner with existing networks for knowledge
translation and dissemination to accelerate the delivery of
evidence-based cancer care. One promising model is Entente,
a European project to increase knowledge transfer activities
related to health research [14].
The EU motto, “United in Diversity,” summarizes both the
challenges and opportunities for the European Cancer Patient’s
Bill ofRights. It is importanttorecognize thattheproposedBill of
Rights resonates across many countries, despite noteworthy
differences in health care financing. Despite differences in
economic resources, both developed and developing countries
can use the proposed framework as a way to prioritize cancer
policy efforts and monitor progress. Equitable distribution of
available resources should be the guiding principle.
To realize thedesiredchange, investmentsmustbemade to
support the data infrastructure to inform policy development.
These enhanced data systems can measure the quality of care
delivered to EU patients. Broader engagement among the
clinicians, policymakers, and countries affected by this effort is
required. Finally, participants should disseminate existing best
practices in care delivery for rapid translation across EU care
delivery systems. These tangible actions will promote patient-
centered, high-quality cancer care for all EU residents.
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EDITOR’SNOTE: See the relatedarticle,“ACatalyst forChange: TheEuropeanCancerPatient’sBill ofRights,”onpages217–224
of this issue.
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